Real World Study of Chronic Viral Hepatitis
Real World Study of Chronic Viral Hepatitis
This study is aimed to collect and analyze clinical data of patients with chronic viral
 hepatitis in the real world, to investigate the long-term outcome of these patients and to
 optimize treatment options based on these data.
Chronic viral hepatitis is defined as infectious liver disease caused by persistent virus
 infection for more than six months. Sustained viral replication and ongoing liver
 inflammation can eventually lead to liver fibrosis/cirrhosis or even hepatocellular
 carcinoma. Chronic viral hepatitis infection causes at least 80% of all liver cancers.

 Though chronic viral hepatitis is a major global health concern, there is still a lack of
 evidence in high quality about the management of chronic viral hepatitis and the long-term
 outcome of patients. The concept of real-world data and research has been officially
 introduced into China since 2010. Real-world evidence, based on real-world data, can help
 practitioners have better understanding of the characteristics of the patients with different
 treatment strategies.

 This study is aimed to collect and analyze clinical data of patients with chronic viral
 hepatitis in the real world, to investigate the long-term outcome of these patients and to
 optimize treatment options based on these data.
Inclusion Criteria:

 1. Informed consent of patients.

 2. Evidence of persistent virus infection for greater than six months [hepatitis C
 virus(HCV) RNA positive, hepatitis B surface antigen(HBsAg) or hepatitis B virus(HBV)
 DNA positive]

 Exclusion Criteria:

 1. Serious psychiatric history, especially depression.

 -  Severe mental illness is defined as major depression or psychosis, suicide
 attempts, hospitalization due to mental illness or a period of disability due to
 mental illness.

 2. Patients with serious diseases of heart, lung, kidney, brain, blood and other
 important organs.

 3. Patients with malignant tumors (excluding those cured).